Funder
Lung Cancer Research Foundation
Foundation for Barnes-Jewish Hospital
National Cancer Institute
Subject
Pharmacology,General Medicine
Reference47 articles.
1. Lung cancer: maintenance therapy and precision medicine in NSCLC;Rosell;Nat. Rev. Clin. Oncol.,2013
2. Survival in glioblastoma: a review on the impact of treatment modalities;Delgado-Lopez;Clin. Transl. Oncol.: Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex.,2016
3. Targeting VEGF in cancer therapy;Donovan;Curr. Probl. Cancer,2006
4. XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC;Zhang;Idrugs,2010
5. Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice;Passaro;OncoTargets Ther.,2016